Hyaluronidase Intradermal Test: What is it and should you do it?

Hyaluronic acid dermal fillers are widely used in aesthetic medicine, and in some cases they may need to be dissolved using hyaluronidase. Before administering hyaluronidase, many practitioners consider performing what is often called a “patch test.” However, this term is technically incorrect.

What Is the Hyaluronidase Intradermal Test?

In aesthetic practice, what people commonly call a patch test for hyaluronidase is actually an intradermal test.

A traditional patch test (used in dermatology for allergies) involves applying a substance to the skin and observing for a delayed reaction over 24–72 hours. This is not how hyaluronidase testing works.

Instead, the test involves:

• Injecting a very small amount of diluted hyaluronidase intradermally

• Usually into the forearm

• Observing the site for local or systemic reactions

The aim is to identify immediate hypersensitivity reactions before using larger therapeutic doses.

Because the substance is injected into the skin rather than applied to it, the correct term is an intradermal test, not a patch test.

Why Is Hyaluronidase Used?

Hyaluronidase is an enzyme that breaks down hyaluronic acid, allowing practitioners to dissolve hyaluronic acid dermal fillers.

It is used in situations such as:

• Dissolving unwanted filler

• Treating overfilling or migration

• Correcting asymmetry

• Managing complications such as vascular compromise

While generally safe, hyaluronidase can very rarely cause allergic or hypersensitivity reactions.

The Science Behind the Test

The rationale for performing an intradermal test is based on allergy detection.

Hyaluronidase products are typically derived from animal sources (commonly ovine or bovine) or produced recombinantly. Because of this, there is a small risk of hypersensitivity reactions.

An intradermal test aims to detect:

• Immediate hypersensitivity reactions

• Local wheal-and-flare responses

• Early allergic responses before full treatment

However, the scientific evidence supporting routine testing is limited.

Key considerations include:

• The incidence of true allergic reactions is very low

• Intradermal tests themselves can produce false positives

• Some allergic reactions may still occur despite a negative test

In other words, the test does not eliminate risk.

Should You Perform the Test?

There is no universal consensus on whether hyaluronidase intradermal testing should be performed routinely.

Practitioners generally fall into two camps.

Practitioners Who Perform the Test

Some clinicians perform an intradermal test before elective filler dissolution because:

• It may identify rare hypersensitivity reactions

• It provides an additional layer of safety

• It offers reassurance for both practitioner and patient

From a medico-legal perspective, some practitioners feel testing demonstrates an extra precautionary step.

Practitioners Who Do Not Perform the Test

Others choose not to perform the test routinely. Their reasoning includes:

• Limited evidence that the test predicts true allergy

• False positives may delay necessary treatment

• The test itself is another injection, which may trigger irritation or misleading reactions

• A negative result does not guarantee safety

For these reasons, some practitioners rely instead on:

• Detailed medical history

• Awareness of previous reactions to bee or wasp stings (which contain hyaluronidase-like enzymes)

• Careful dosing and monitoring during treatment

  
  

The Ethical Debate: Could Not Testing Cause Harm?

One argument in favour of testing is that failing to test might discourage the use of hyaluronidase when it is needed.

If a practitioner is concerned about allergic reactions and has not performed prior testing, they may hesitate to use hyaluronidase. In theory, this could lead to delayed treatment, particularly in situations where filler should be dissolved.

In aesthetic medicine, timely access to hyaluronidase is crucial because it is the primary treatment for hyaluronic acid filler complications.

For this reason, some clinicians feel testing beforehand allows them to use the enzyme more confidently when needed.

Why Some Practitioners Test Electively but Not in Emergencies

A commonly discussed paradox is that some practitioners perform intradermal testing in elective situations but skip it in emergencies.

The rationale comes down to risk versus urgency.

Elective Dissolving

In non-urgent situations (for example dissolving unwanted filler):

• There is time to perform the test

• The treatment can be delayed safely

• Practitioners may prefer an additional safety check

• 
  

Emergency Situations

In emergencies such as vascular occlusion, the situation is very different.

Delayed treatment can lead to:

• Skin necrosis

• Permanent scarring

• In extremely rare cases, visual complications

In these scenarios, the priority is rapid administration of high-dose hyaluronidase to restore blood flow.

Waiting for an intradermal test result could delay treatment and increase the risk of permanent tissue damage.

For this reason, many clinical protocols recommend immediate treatment without prior testing in emergencies.

The Takeaway

The hyaluronidase “patch test” commonly discussed in aesthetics is actually an intradermal injection test.

While it is designed to detect hypersensitivity reactions, the evidence supporting routine testing is mixed, and practice varies among clinicians.

Key points include:

• The correct term is intradermal test, not patch test

• Allergic reactions to hyaluronidase are rare

• A test may provide reassurance but does not eliminate risk

• In emergency situations, treatment should not be delayed for testing

Ultimately, the decision to perform intradermal testing should be based on clinical judgement, patient history, and practitioner experience.

As with many areas of aesthetic medicine, the priority is ensuring practitioners are trained to recognise complications and manage them promptly and safely.This blog explores what the test actually is, the science behind it, and the ongoing debate about whether it should be performed routinely.